Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Phase II Trial of TPI 287 in Patients With Metastatic Prostate Cancer

This study has been terminated.
(Sponsor could no longer support; enrollment stopped August 2008.)
Information provided by (Responsible Party):
Cortice Biosciences, Inc. Identifier:
First received: May 24, 2007
Last updated: January 9, 2014
Last verified: January 2014
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2008
  Primary Completion Date: August 2008 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: July 16, 2012